Moloney Securities Asset Management, LLC Revolution Medicines, Inc. Transaction History

Moloney Securities Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$20.76 - $30.09 $197,220 - $285,855	-9,500 Reduced 44.92%	11,650 $252,000
Q4 2022 Jan 30, 2023	SELL	$17.68 - $25.53 $79,560 - $114,885	-4,500 Reduced 17.54%	21,150 $503,000
Q3 2022 Oct 31, 2022	SELL	$17.46 - $26.0 $248,805 - $370,500	-14,250 Reduced 35.71%	25,650 $506,000
Q2 2022 Aug 03, 2022	BUY	$14.54 - $27.17 $580,146 - $1.08 Million	39,900 New	39,900 $778,000
Q2 2021 Jul 26, 2021	SELL	$29.0 - $47.44 $130,500 - $213,480	-4,500 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$37.21 - $54.43 $76,280 - $111,581	-2,050 Reduced 31.3%	4,500 $206,000
Q4 2020 Feb 08, 2021	SELL	$30.19 - $45.49 $15,095 - $22,745	-500 Reduced 7.09%	6,550 $259,000
Q3 2020 Oct 20, 2020	BUY	$22.61 - $34.8 $159,400 - $245,339	7,050 New	7,050 $245,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.